Polyphenols: Potential anti‐inflammatory agents for treatment of metabolic disorders

Ample evidence highlights the potential benefits of polyphenols in health status especially in obesity‐related metabolic disorders such as insulin resistance, type 2 diabetes, and cardiovascular diseases. Mechanistically, due to the key role of “Metainflammation” in the pathomechanism of metabolic d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Phytotherapy research 2022-01, Vol.36 (1), p.415-432
Hauptverfasser:	Zamani‐Garmsiri, Fahimeh, Emamgholipour, Solaleh, Rahmani Fard, Soheil, Ghasempour, Ghasem, Jahangard Ahvazi, Roya, Meshkani, Reza
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use Caffeic acid Cardiovascular diseases Chlorogenic acid Clinical trials Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - drug therapy Ellagic acid Genistein Humans In vivo methods and tests Inflammation Insulin Insulin resistance Metabolic Diseases - drug therapy Metabolic disorders Obesity Polyphenols Polyphenols - pharmacology Polyphenols - therapeutic use Silymarin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!